Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 132

    1.

    The role of bisphosphonates in multiple myeloma.

    Kyle RA.

    Ann Intern Med. 2000 May 2;132(9):734-6. No abstract available. PMID: 10787368 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Aetiology of bone disease and the role of bisphosphonates in multiple myeloma.

    Ashcroft AJ, Davies FE, Morgan GJ.

    Lancet Oncol. 2003 May;4(5):284-92. Review.PMID: 12732166 [PubMed - indexed for MEDLINE]Related articles

    3.

    Bisphosphonates in multiple myeloma: current status; future perspectives.

    Jantunen E, Laakso M.

    Br J Haematol. 1996 Jun;93(3):501-6. Review. No abstract available. PMID: 8652366 [PubMed - indexed for MEDLINE]Related articles

    4.

    Bisphosphonates may potentiate effects of thalidomide-dexamethasone combination in advanced multiple myeloma.

    Ural AU, Avcu F.

    Am J Hematol. 2006 May;81(5):385-6; author reply 386. No abstract available. PMID: 16628715 [PubMed - indexed for MEDLINE]Related articles

    5.

    Bisphosphonates in the prevention and treatment of bone metastases.

    Ramaswamy B, Shapiro CL.

    Oncology (Williston Park). 2003 Sep;17(9):1261-70; discussion 1270-2, 1277-8, 1280. Review.PMID: 14569853 [PubMed - indexed for MEDLINE]Related articles

    6.

    Metastatic bone disease and the role of bisphosphonates.

    Ellis MJ.

    Br J Hosp Med. 1996 Oct 2-15;56(7):339-45. Review. No abstract available. PMID: 8899222 [PubMed - indexed for MEDLINE]Related articles

    7.

    Bisphosphonates in multiple myeloma.

    Djulbegovic B, Wheatley K, Ross J, Clark O, Bos G, Goldschmidt H, Cremer F, Alsina M, Glasmacher A.

    Cochrane Database Syst Rev. 2002;(3):CD003188. Review.PMID: 12137679 [PubMed - indexed for MEDLINE]Related articles

    8.

    Managing cancer-related skeletal events with bisphosphonates.

    Rule S.

    Hosp Med. 2004 Jun;65(6):355-60. Review.PMID: 15222212 [PubMed - indexed for MEDLINE]Related articles

    9.

    Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.

    Ibrahim A, Scher N, Williams G, Sridhara R, Li N, Chen G, Leighton J, Booth B, Gobburu JV, Rahman A, Hsieh Y, Wood R, Vause D, Pazdur R.

    Clin Cancer Res. 2003 Jul;9(7):2394-9.PMID: 12855610 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.

    Body JJ, Greipp P, Coleman RE, Facon T, Geurs F, Fermand JP, Harousseau JL, Lipton A, Mariette X, Williams CD, Nakanishi A, Holloway D, Martin SW, Dunstan CR, Bekker PJ.

    Cancer. 2003 Feb 1;97(3 Suppl):887-92.PMID: 12548591 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [Bisphosphonates in the therapy of cancer patients]

    Jantunen E, Kumpulainen E.

    Duodecim. 1999;115(1):27-32. Review. Finnish. No abstract available. PMID: 11830857 [PubMed - indexed for MEDLINE]Related articles

    12.

    Introduction: the evolving role of bisphosphonate therapy in multiple myeloma.

    Raje N, Anderson KC.

    Blood. 2000 Jul 15;96(2):381-3. Review. No abstract available. PMID: 10887095 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Biphosphonates and multiple myeloma]

    Mazières B, Laroche M, Cantagrel A.

    Bull Cancer. 1993;80(10 Suppl):45-9. French. No abstract available. PMID: 8081030 [PubMed - indexed for MEDLINE]Related articles

    14.

    Bone complications in multiple myeloma.

    Berenson JR, Rajdev L, Broder M.

    Cancer Biol Ther. 2006 Sep;5(9):1082-5. Epub 2006 Sep 20. Review.PMID: 16969119 [PubMed - indexed for MEDLINE]Related articles

    15.

    Bone disease in multiple myeloma: new markers, new treatments.

    Joshua D.

    Intern Med J. 2001 Jul;31(5):261-3. No abstract available. PMID: 11512595 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Effects of pamidronate disodium (Bonin) combined with chemotherapy on bone pain in multiple myeloma]

    Leng Y, Chen SL, Shi HZ.

    Space Med Med Eng (Beijing). 2002 Oct;15(5):377-8. Chinese. PMID: 12449148 [PubMed - indexed for MEDLINE]Related articles

    17.

    Bisphosphonates and radiation therapy for palliation of metastatic bone disease.

    Hoskin PJ.

    Cancer Treat Rev. 2003 Aug;29(4):321-7. Review.PMID: 12927572 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Medical treatment of multiple myeloma]

    Astaldi G, Meardi G, Yalçin B.

    Cancro. 1973;26(5):319-37. Italian. No abstract available. PMID: 4793834 [PubMed - indexed for MEDLINE]Related articles

    19.

    Should bisphosphonates be the treatment of choice for metastatic bone disease?

    Coleman RE.

    Semin Oncol. 2001 Aug;28(4 Suppl 11):35-41. Review.PMID: 11544574 [PubMed - indexed for MEDLINE]Related articles

    20.

    Perspective study on pamidronate in stage I multiple myeloma.

    Caparrotti G, Catalano L, Feo C, Vallone R, Pagnini D, Rotoli B.

    Hematol J. 2003;4(6):459-60. No abstract available. PMID: 14671624 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data